View in EDS HTML Full Text PDF Full Text

Intravenous ferric carboxymaltose in heart failure with iron deficiency (FAIR‐HF2 DZHK05 trial): Sex‐specific outcomes.

Saved in:
Bibliographic Details
Title: Intravenous ferric carboxymaltose in heart failure with iron deficiency (FAIR‐HF2 DZHK05 trial): Sex‐specific outcomes.
Authors: Karakas, Mahir1,2 (AUTHOR) m.karakas@uke.de, Friede, Tim3,4 (AUTHOR), Butler, Javed5,6 (AUTHOR), Talha, Khawaja M.7 (AUTHOR), Placzek, Marius3,4 (AUTHOR), Asendorf, Thomas3,4 (AUTHOR), Diek, Monika8 (AUTHOR), Nosko, Anna1 (AUTHOR), Stas, Adriane4,9 (AUTHOR), Kluge, Stefan1 (AUTHOR), Jarczak, Dominik1 (AUTHOR), DeHeer, Geraldine1 (AUTHOR), Rybczynski, Meike2,10 (AUTHOR), Bayes‐Genis, Antoni11 (AUTHOR), Böhm, Michael12 (AUTHOR), Coats, Andrew J.S.13 (AUTHOR), Edelmann, Frank14,15 (AUTHOR), Filippatos, Gerasimos16 (AUTHOR), Hasenfuß, Gerd4,17 (AUTHOR), Haverkamp, Wilhelm8 (AUTHOR)
Source: European Journal of Heart Failure. Nov2025, Vol. 27 Issue 11, p2328-2342. 15p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:13889842
DOI:10.1002/ejhf.3742